Cocrystal Pharma (COCP) Change in Receivables (2010 - 2021)
Cocrystal Pharma (COCP) posted Change in Receivables of -$6000.0 for Q4 2021, down 200.0% sequentially from $6000.0 in Q3 2021, and up 76.0% YoY from -$3409.1 in Q4 2020.
Cocrystal Pharma (COCP) Change in Receivables (2010 - 2021) Analysis & Trends
Cocrystal Pharma has reported Change in Receivables for 9 years, with the latest figure at -$6000.0 in Q4 2021.
- Quarterly Change in Receivables rose 76.0% year-over-year to -$6000.0 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was -$556000.0 (down 81.7% YoY) and the FY2021 annual result came in at -$556000.0, down 531.82% from the prior year.
- Change in Receivables retreated to -$6000.0 in Q4 2021 per COCP's latest filing, from $6000.0 in the prior quarter.
- Over five years, Change in Receivables peaked at $1.1 million in Q1 2019 and troughed at -$556000.0 in Q1 2021.
- A 4-year average of $2461.5 and a median of -$21000.0 in 2017 frame the typical range for Change in Receivables.
- The sharpest annual moves came in 2017 and 2021: Change in Receivables sank 80.0% in 2017, then surged 154.55% in 2021.
- Over 4 years, Change in Receivables stood at $1000.0 in 2017, then slumped by 12500.0% to -$124000.0 in 2019, then jumped by 79.84% to -$25000.0 in 2020, then soared by 76.0% to -$6000.0 in 2021.
- According to Business Quant data, Change in Receivables over the past three periods registered -$6000.0, $6000.0, and -$556000.0 for Q4 2021, Q3 2021, and Q1 2021 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -53.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 117.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 31.60 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 94.29 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 37.16 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Cocrystal Pharma | 15.65 Mn | 13.33 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -6,000.00 |
| Dec 31, 2021 | -6,000.00 |
| Sep 30, 2021 | 6,000.00 |
| Sep 30, 2021 | 6,000.00 |
| Mar 31, 2021 | -556,000.00 |
| Mar 31, 2021 | -556,000.00 |
| Dec 31, 2020 | -25,000.00 |
| Dec 31, 2020 | -25,000.00 |
| Sep 30, 2020 | -11,000.00 |
| Sep 30, 2020 | -11,000.00 |
| Dec 31, 2019 | -124,000.00 |
| Dec 31, 2019 | -124,000.00 |
| Sep 30, 2019 | -146,000.00 |
| Sep 30, 2019 | -146,000.00 |
| Jun 30, 2019 | -164,000.00 |
| Jun 30, 2019 | -164,000.00 |
| Mar 31, 2019 | 1.08 Mn |
| Mar 31, 2019 | 1.08 Mn |
| Dec 31, 2017 | 1,000.00 |
| Dec 31, 2017 | 1,000.00 |